Ekso Bionics Holdings, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Ekso Bionics Holdings, Inc. has filed an amended annual report (Form 10-K/A) to include Part III information and updated certifications.
NASDAQ
Ekso Bionics Holdings, Inc. reported a 29% decrease in revenue for 2025 and announced a definitive agreement to merge with Applied Digital Cloud Corporation, with the combined entity to be renamed ChronoScale Corporation.
NASDAQ
10-K: Ekso Bionics Reports Fiscal Year 2024 Results, Navigates Reimbursement and Supply Chain Challenges
Ekso Bionics' 2024 10-K filing reveals a year of strategic shifts, including CMS reimbursement approval for Ekso Indego Personal, alongside ongoing financial losses and efforts to refine operational efficiencies.
NASDAQ
Ekso Bionics' 10-K filing outlines the details of its common stock, including dividend and voting rights, and describes anti-takeover provisions under Nevada law.